VACCINES ON DEMAND

Making vaccines where they're needed when they're needed

OVERVIEW

With the Vaccines on Demand program, BARDA'S DRIVe and CBRN division are seeking innovative technologies that advance the capability for manufacturing vaccines on demand at the point-of-service.

Vaccination is a critical medical countermeasure for infectious disease threats. To facilitate the rapid deployment of vaccines during outbreaks/pandemics, progress toward decentralized vaccine manufacturing is needed.

APPROACH

Support the development of Vaccines on Demand technologies/ systems for distributed vaccine production at or near the point-of-service, with a particular focus on nucleic acid-based vaccines.

We are specifically interested in platforms that have:

  • Easily definable inputs
  • Logistically useful footprint
  • Minimal to no release testing
  • Small-scale validation
  • In-line formulation capabilities
  • Plug and play capability

Program Goals

Create Nucleic Acid-based Vaccines

Allow for flexible design and rapid production

>1000 Doses Per Batch

Ensure large-batch capability for prompt response

One Batch Within Seven Days

Optimize End to End Production Cycle

VACCINES ON DEMAND

Funding
Opened

10/22/22

Special
Instructions

#1

Get PDF

Funding Closed

2/28/23

Looking for General FAQ?
General faq

Vaccines On Demand program is closed